Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.
Catalyst Watch: Tesla's Robotaxi Reveal, AI Events for Nvidia, AMD, and HP Enterprise
Q3 Pharma and Biotech Layoffs in Charts: More Than 1000 Each in July and August
Capricor Stock Rallies 20% on DMD Data Presentation Update
CRISPR Therapeutics Analyst Ratings
Editas Medicine Reports Sale Of Certain Future License Fees, Other Payments Owed Under Cas9 License Agreement With Vertex To DRI Healthcare Trust Subsidiary For Upfront Cash Payment Of $57M
Avidity Gets FDA Partial Clinical Hold Lifted on DM1 Drug Candidate